Clinicopathologic Conference (CPC) 02/05/16

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
Young man with progressive neurological decline. History of present illness 21 yo male with a progressive neurological decline over 2 months – Difficulties.
Parkinson’s Disease (PD)
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Sporadic ataxia and multiple system atrophy Sid Gilman MD Department of Neurology University of Michigan.
Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
Idiopathic parkinson’s disease (IPD)
Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Aging of the Nervous System: Functional Changes P.S. Timiras.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Prepared by: Muhammad Ibrahim khan BS.PT(Pak), MS.PT(Pak), NCC(AKUH), CHPE(KMU)
Dementia with Lewy Bodies
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Basal ganglia & cerebellar pathology
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Plus By: Glen Estrosos.
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
MOTOR AREAS EXTRAPYRAMIDAL SYSTEM
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Alex Wiemann. Function of Nervous System Coordinates actions and transmits signals between parts of a body.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
PARKINSON’S DISEASE.
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Pathogenesis and pathology of parkinsonism
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Localising the lesion – where in the nervous system?
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Neurological Examination Dr Andrew Gale 23 Feb 2010.
Clinical Pathology Conference October 16, 2015 Kara Wyant, MD Neurology Resident PGY-4 Department of Neurology, UPMC Julia Kofler, MD Assistant Professor.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
Direct motor pathway Corticospinal pathway.
RB Clincopathologic Conference (CPC) 3/18/2016 Thomas Shoemaker, MD Ronald Hamilton, MD.
Neurodegenerative Neuropath. The Neurodegenerates  Alzheimer’s Disease  Parkinson’s Disease  Lewy Body Dementia  Multiple Systems Atrophy  FTD /
Parkinson’s disease by Syed Baseeruddin Alvi (09).
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
CM Clincopathologic Conference (CPC) April 15 th 2016 Neurology Resident: Kiruba Dharaneeswaran Pathologist: Ronald Hamilton.
Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity),
59 year old man w visual hallucinations
Dementia with Lewy Bodies
The ageing brain Volume reduction: begins around 50 with a loss of brain weight of around 2-3% per decade Changes in nerve cell numbers and size - various.
GM Clincopathologic Conference (CPC) 11/20/2015
A 22-year-old woman with progressive ataxia and feet dystonia
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
“Other” Dementias Alistair McVean.
Atypical Parkinsonian Syndromes
Assessing your patient
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
NEURODEGENERATIVE DISEASES
CNS.
Parkinson’s Disease Definitions Disease features Pathology
Introduction to degenerative brain disease
Presentation transcript:

Clinicopathologic Conference (CPC) 02/05/16 Neurology Resident: Diana Mnatsakanova Pathologist: Ronald Hamilton

History HPI: AW is a 90 yo woman with hx of gait instability and falls who was followed by movement disorders clinic. Problems with balance started since MVA in 2007, after which she started experiencing gait instability and falls. She typically fell backwards. She also had noted weakness which was mostly related to slowness. She had noted left sided rest tremor in 2013 which progressed to the right side. No hx of hallucination, confusion, delusions, REM sleep abnormalities. She was started on a trial of Sinemet in 2014 up to 2 tabs QID with minimal improvement as she continued to have retropulsion. Tremors did not improve. Over time, her gait worsened, requiring use of a walker. She was bedridden by the end of 2015 at which point CT of chest/abdomen revealed numerous masses, pulmonary nodules and lymphadenopathy; Care was transitioned to comfort measures. ROS was positive for urinary incontinence and memory problems (mostly amnestic without fluctuations). PMH: MVA in 2007, concussion, migraine headaches, vertigo, TIAs Medications: Asa, Ritalin, Zoloft, Ca-VitD

Examination MENTAL STATUS: Alert , oriented x4, speech without dysarthria, language intact. Concentration and fund of knowledge appropriate. Present Glabellar sign. CN: EOMs with intact range, smooth pursuits slightly saccadic, saccades with normal speed and range, absent nystagmus, absent square wave jerks; otherwise unremarkable MOTOR: low amplitude low frequency rest tremor was present LUE>RUE; tone was increased mildly LUE>RUE, mild bradykinesia present more on LUE > RUE. Full strength throughout SENS: intact to light touch REFLEX: : 2+ throughout, plantar responses flexor, absent Hoffman’s sign COORD: no dysmetria on FTN, HTS, Negative Romberg GAIT: able to stand up with assistance slowly, shortened stride length, slow pace and intermittent hesitation, turns with multiple steps, some postural truncal swaying during ambulation, stance with normal base, pull test was positive, normal arm swing.

Radiology

Differential Diagnosis Atypical Parkinsonism – given early falls with retropulsion, poor response to levodopa. Did have urinary incontinence but this was noted immediately after MVA without signs of progression. Overall hx and exam do not fit any particular type of parkinsonian plus syndrome such as CBD, PSP, or MSA Dementia with Lewy bodies – memory difficulties, inattentive, although no hx of hallucination or fluctuating confusion Idiopathic Parkinson Disease – asymmetric presentation, gradual progression Vascular Parkinsonism- white matter changes, hydrocephalus ex vacuo on MRI

Predicted Pathology Parkinson’s Disease Predicted Gross pathology: Pallor of the substantia nigra (SN) and possibly locus ceruleous Cortical Atrophy and ventricular dilatation Predicted Micro pathology: Loss of neurons in the SN; presence of Lewy bodies in the SN, locus ceruleus, dorsal motor nuclear of vagus, nucleus basalis of Meynert Cortical Lewy bodies Immunohistochemical features: α-synuclein and ubiquitin glial inclusions; Lewy neurites with α-synuclein, ubiquitin, or neurofilaments Dementia with Lewy Bodies Cortical and brain stem Lewy bodies Three levels of involvement: brain stem, limbic, and neocortical Diffuse and neuritic plaques and neurofibrillary tangles

Predicted Pathology Multiple System Atrophy Predicted Gross pathology: MSA-P: atrophy and discoloration of the putamen, atrophy of caudate nucleus MSA-C: atrophy of cerebellum, middle cerebellar peduncle, and pons Pallor of the substantia nigra (SN) in both types Predicted Micro pathology: MSA-P: neuronal loss and astrocytosis in the striatonigral system MSA-C: cerebellar degeneration with Purkinje cell loss Immunohistochemical features: α -synuclein, ubiquitin, and tau glial cytoplasmic inclusions in the pyramidal, extrapyramidal, limbic, corticocerebellar, and supraspinal autonomic systems

Virtual microscopy Frontal CTX Slide A Midbrain Slide G H&E Abeta Tau Midbrain Slide G Hippocampus Slide E